Latest Property Portfolio News

Nanoveu Limited spotlighted its cutting-edge ultra-low-power AI semiconductor technology and strategic collaborations at the Pitt Street Research Semiconductor Conference 2025, signaling a bold push into edge AI markets.

Anagenics Limited has completed a significant restructuring to simplify operations and issued 35 million shares to FOS Capital as part of this process. The company confirms its going concern status and outlines plans for organic and acquisitive growth over the next year.

WOTSO Group reports robust expansion with 31 flexible workspace locations and a $299 million property portfolio, trading at a notable discount to net asset value. The company’s suburban focus and operational discipline underpin sustained revenue and occupancy gains.

ClearVue Technologies has secured its first commercial rooftop contract in Sydney’s CBD, supplying innovative solar glass for the City Tattersalls Club redevelopment to boost sustainability and energy efficiency.

FBR Limited wraps up its US Demonstration Program, secures $6.3 million in capital, and appoints Mark Pivac as CEO amid a 70% cost reduction drive. Strategic collaborations with Samsung Heavy Industries and Liebherr signal broader automation ambitions.

Actinogen Medical advances its XanaMIA phase 2b/3 Alzheimer’s trial with faster patient enrolment and expands clinical sites, while achieving a pivotal FDA meeting outcome for its depression program. The company maintains a strong cash position, supporting ongoing development and commercialization efforts.

First Graphene Limited reported a successful A$2.4 million capital raise alongside promising progress in its PureGRAPH-CEM product trials in the UK and South Africa, while securing key patents and expanding distribution across Asia and South America.

EcoGraf Limited has advanced its vertically integrated battery anode materials business with a US$105 million loan mandate for the Epanko Graphite Mine, expanded mining licences, and progress in purification technology and community initiatives.

Desane Group Holdings reports a $6.6 million uplift in its property portfolio valuation, driven by strong leasing activity and market demand, enhancing shareholder value with a 9-cent increase in net tangible assets per share.

Desane Group Holdings has secured a seven-year lease extension with Signature Orthopaedics at its Lane Cove property, guaranteeing $5 million in rental income through 2032. This deal reinforces Desane’s strategy to maintain stable medium-term cash flows.

Hudson Investment Group is actively exploring sale and joint venture opportunities for key properties while managing a negative cash flow quarter, signaling strategic shifts ahead.

Echo IQ Limited marked a pivotal quarter with FDA clearance for EchoSolv AS, strategic US partnerships, and a clear path toward reimbursement and broader commercialisation.